Skip to Main Content

Paper Details

A phase I/Ib trial and biological correlate analysis of neoadjuvant SBRT with single-dose durvalumab in HPV-unrelated locally advanced HNSCC.
Nat Cancer
27
2022
anti-PD-L1, effector, effector T, head and neck squamous cell carcinomas, human papilloma virus, immunosuppressive cells, locally advanced HNSCC, patients
Author NameAffiliation
Laurel B DarraghUniversity of Colorado Denver at Anschutz Medical Campus
Laurel B DarraghUniversity of Colorado Denver at Anschutz Medical Campus
Shilpa BhatiaUniversity of Colorado Denver at Anschutz Medical Campus
Adrie van BokhovenUniversity of Colorado Denver at Anschutz Medical Campus
Kimberly R JordanUniversity of Colorado Denver at Anschutz Medical Campus
Antonio JimenoUniversity of Colorado School of Medicine
Angelo D'AlessandroUniversity of Colorado Denver at Anschutz Medical Campus
Angelo D'AlessandroUniversity of Colorado Denver at Anschutz Medical Campus
Sana D KaramUniversity of Colorado Denver at Anschutz Medical Campus
Sana D KaramUniversity of Colorado Denver at Anschutz Medical Campus
  • 1 - 10

Datasets

Release 1.2